{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:06:00Z","timestamp":1790643960296,"version":"4.1.0"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Friedrich Ataxia Research Alliance"},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council (NHMRC) \u2014 CSL Gustav Nossal postgraduate research scholarship","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council (ARC) Future Fellowship","doi-asserted-by":"publisher","award":["FT140100047"],"award-info":[{"award-number":["FT140100047"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"ARC special Initiative Stem Cells Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004752","name":"Victorian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004752","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.ijcard.2016.03.040","type":"journal-article","created":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T23:49:06Z","timestamp":1458604146000},"page":"37-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Using human pluripotent stem cells to study Friedreich ataxia cardiomyopathy"],"prefix":"10.1016","volume":"212","author":[{"given":"Duncan E.","family":"Crombie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin F.","family":"Pera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin B.","family":"Delatycki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7408-9453","authenticated-orcid":false,"given":"Alice","family":"P\u00e9bay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.03.040_bb0005","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1177\/0883073812448230","article-title":"Clinical features of Friedreich ataxia","volume":"27","author":"Delatycki","year":"2012","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0010","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","article-title":"Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion","volume":"271","author":"Campuzano","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0015","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/hmg\/6.11.1771","article-title":"Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes","volume":"6","author":"Campuzano","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0020","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1086\/301680","article-title":"The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure","volume":"62","author":"Bidichandani","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0025","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1093\/nar\/gkm271","article-title":"Repeat-induced epigenetic changes in intron 1 of the frataxin gene and its consequences in Friedreich ataxia","volume":"35","author":"Greene","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0030","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1056\/NEJM199610173351601","article-title":"Clinical and genetic abnormalities in patients with Friedreich's ataxia","volume":"335","author":"Durr","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0035","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jns.2011.05.023","article-title":"Mortality in Friedreich ataxia","volume":"307","author":"Tsou","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0040","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/(SICI)1096-8628(19991119)87:2<168::AID-AJMG8>3.0.CO;2-2","article-title":"Clinical and genetic study of Friedreich ataxia in an Australian population","volume":"87","author":"Delatycki","year":"1999","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0045","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.echo.2011.04.004","article-title":"Early changes in left ventricular long-axis function in Friedreich ataxia: relation with the FXN gene mutation and cardiac structural change","volume":"24","author":"Mottram","year":"2011","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0050","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/CIRCULATIONAHA.111.059477","article-title":"G. mitochondrial protection with idebenone in cardiac or neurological outcome study, the heart in Friedreich ataxia: definition of cardiomyopathy, disease severity, and correlation with neurological symptoms","volume":"125","author":"Weidemann","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0055","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s00246-008-9305-1","article-title":"The longitudinal course of cardiomyopathy in Friedreich's ataxia during childhood","volume":"30","author":"Kipps","year":"2009","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0060","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/hrt.81.2.141","article-title":"Marked variation in the cardiomyopathy associated with Friedreich's ataxia","volume":"81","author":"Dutka","year":"1999","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.10419","article-title":"Cardiac energetics correlates to myocardial hypertrophy in Friedreich's ataxia","volume":"53","author":"Bunse","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0070","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1001\/jamaneurol.2015.1855","article-title":"A 22-year follow-up study of long-term cardiac outcome and predictors of survival in Friedreich ataxia","volume":"72","author":"Pousset","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0075","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.amjcard.2011.09.025","article-title":"Analysis of echocardiograms in a large heterogeneous cohort of patients with friedreich ataxia","volume":"109","author":"Regner","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0080","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s001090000162","article-title":"The GAA repeat expansion in intron 1 of the frataxin gene is related to the severity of cardiac manifestation in patients with Friedreich's ataxia","volume":"78","author":"Bit-Avragim","year":"2001","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116396","article-title":"The pathogenesis of cardiomyopathy in Friedreich ataxia","volume":"10","author":"Koeppen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0090","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/ng1097-215","article-title":"Aconitase and mitochondrial iron\u2013sulphur protein deficiency in Friedreich ataxia","volume":"17","author":"Rotig","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0095","doi-asserted-by":"crossref","first-page":"22763","DOI":"10.1074\/jbc.274.32.22763","article-title":"Yeast and human frataxin are processed to mature form in two sequential steps by the mitochondrial processing peptidase","volume":"274","author":"Branda","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0100","doi-asserted-by":"crossref","first-page":"9132","DOI":"10.1021\/bi1013062","article-title":"Human frataxin is an allosteric switch that activates the Fe-S cluster biosynthetic complex","volume":"49","author":"Tsai","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016199","article-title":"Mammalian frataxin: an essential function for cellular viability through an interaction with a preformed ISCU\/NFS1\/ISD11 iron\u2013sulfur assembly complex","volume":"6","author":"Schmucker","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0110","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrm1620","article-title":"Iron\u2013sulphur cluster biogenesis and mitochondrial iron homeostasis","volume":"6","author":"Rouault","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0115","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1073\/pnas.0709691105","article-title":"Hydrogen peroxide scavenging rescues frataxin deficiency in a drosophila model of Friedreich's ataxia","volume":"105","author":"Anderson","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0120","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1096\/fj.05-5709com","article-title":"Causative role of oxidative stress in a drosophila model of Friedreich ataxia","volume":"21","author":"Llorens","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0125","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng0897-352","article-title":"Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologue","volume":"16","author":"Wilson","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0130","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1126\/science.276.5319.1709","article-title":"Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin","volume":"276","author":"Babcock","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0135","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1096\/fj.05-4212fje","article-title":"Reduction of Caenorhabditis elegans frataxin increases sensitivity to oxidative stress, reduces lifespan, and causes lethality in a mitochondrial complex II mutant","volume":"20","author":"Vazquez-Manrique","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0140","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1474-9726.2005.00149.x","article-title":"Reduced expression of frataxin extends the lifespan of Caenorhabditis elegans","volume":"4","author":"Ventura","year":"2005","journal-title":"Aging Cell"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0145","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/hmg\/9.8.1219","article-title":"Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation","volume":"9","author":"Cossee","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0150","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s100480100118","article-title":"Rescue Of the Friedreich's ataxia knockout mouse by human YAC transgenesis","volume":"3","author":"Pook","year":"2001","journal-title":"Neurogenetics"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0155","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ygeno.2006.06.015","article-title":"GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology","volume":"88","author":"Al-Mahdawi","year":"2006","journal-title":"Genomics"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0160","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ygeno.2004.04.003","article-title":"GAA repeat instability in Friedreich ataxia YAC transgenic mice","volume":"84","author":"Al-Mahdawi","year":"2004","journal-title":"Genomics"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0165","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.1098991","article-title":"Frataxin acts as an iron chaperone protein to modulate mitochondrial aconitase activity","volume":"305","author":"Bulteau","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0170","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/hmg\/10.19.2099","article-title":"Frataxin expression rescues mitochondrial dysfunctions in FRDA cells","volume":"10","author":"Tan","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0175","doi-asserted-by":"crossref","first-page":"11492","DOI":"10.1073\/pnas.96.20.11492","article-title":"Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia","volume":"96","author":"Lodi","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0180","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0960-8966(00)00108-5","article-title":"Mitochondrial impairment of human muscle in Friedreich ataxia in vivo","volume":"10","author":"Vorgerd","year":"2000","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0185","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1093\/hmg\/ddi367","article-title":"RNAi-mediated suppression of the mitochondrial iron chaperone, frataxin, in drosophila","volume":"14","author":"Anderson","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0190","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nm.3510","article-title":"Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich's ataxia","volume":"20","author":"Perdomini","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0195","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/hmg\/ddm346","article-title":"The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues","volume":"17","author":"Al-Mahdawi","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0200","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1172\/JCI18107","article-title":"Frataxin deficiency in pancreatic islets causes diabetes due to loss of beta cell mass","volume":"112","author":"Ristow","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0205","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0014-5793(02)02251-2","article-title":"Frataxin knockin mouse","volume":"512","author":"Miranda","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0210","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1089\/hum.2013.180","article-title":"Cell and gene therapy for Friedreich ataxia: progress to date","volume":"25","author":"Evans-Galea","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0215","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.mito.2009.01.007","article-title":"Overexpression of the yeast frataxin homolog (Yfh1): contrasting effects on iron\u2013sulfur cluster assembly, heme synthesis and resistance to oxidative stress","volume":"9","author":"Seguin","year":"2009","journal-title":"Mitochondrion"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0220","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nchembio815","article-title":"Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia","volume":"2","author":"Herman","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0225","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.nbd.2005.11.014","article-title":"Gene expression profiling in frataxin deficient mice: microarray evidence for significant expression changes without detectable neurodegeneration","volume":"22","author":"Coppola","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0230","doi-asserted-by":"crossref","first-page":"6701","DOI":"10.1074\/jbc.M408717200","article-title":"Friedreich's ataxia, no changes in mitochondrial labile iron in human lymphoblasts and fibroblasts: a decrease in antioxidative capacity?","volume":"280","author":"Sturm","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0235","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1182\/blood-2008-06-161919","article-title":"Cell functions impaired by frataxin deficiency are restored by drug-mediated iron relocation","volume":"112","author":"Kakhlon","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0240","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/hmg\/9.2.275","article-title":"Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia","volume":"9","author":"Bradley","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0245","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1017\/S0317167100006260","article-title":"Complex I and ATP content deficiency in lymphocytes from Friedreich's ataxia","volume":"36","author":"Heidari","year":"2009","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0250","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.mito.2010.12.003","article-title":"Blood cells from Friedreich ataxia patients harbor frataxin deficiency without a loss of mitochondrial function","volume":"11","author":"M.A. Selak","year":"2011","journal-title":"Mitochondrion"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0255","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/15230860050192233","article-title":"Sensitivity of FRDA lymphoblasts to salts of transition metal ions","volume":"2","author":"Wong","year":"2000","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0260","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/hmg\/ddg187","article-title":"Decreased expression of genes involved in sulfur amino acid metabolism in frataxin-deficient cells","volume":"12","author":"Tan","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0265","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0270","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/74447","article-title":"Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro","volume":"18","author":"Reubinoff","year":"2000","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0275","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/dvdy.10430","article-title":"Long-term culture of human embryonic stem cells in feeder-free conditions","volume":"229","author":"Rosler","year":"2004","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0280","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0140-6736(12)60028-2","article-title":"Embryonic stem cell trials for macular degeneration: a preliminary report","volume":"379","author":"Schwartz","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0285","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1002\/stem.149","article-title":"Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration","volume":"27","author":"Lu","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0290","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.mce.2007.11.010","article-title":"PGD-derived human embryonic stem cell lines as a powerful tool for the study of human genetic disorders","volume":"282","author":"Ben-Yosef","year":"2008","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0295","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0300","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Slukvin, II, J.A. Thomson, induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0305","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0310","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/stem.1425","article-title":"Identification of unsafe human induced pluripotent stem cell lines using a robust surrogate assay for pluripotency","volume":"31","author":"Polanco","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0315","doi-asserted-by":"crossref","first-page":"14234","DOI":"10.1073\/pnas.1103509108","article-title":"Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors","volume":"108","author":"Ban","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0320","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.stem.2010.08.012","article-title":"Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA","volume":"7","author":"Warren","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0325","doi-asserted-by":"crossref","first-page":"787","DOI":"10.5966\/sctm.2013-0036","article-title":"Efficient generation of integration-free human induced pluripotent stem cells from keratinocytes by simple transfection of episomal vectors","volume":"3","author":"Piao","year":"2014","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0330","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature09798","article-title":"Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells","volume":"471","author":"Lister","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0335","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature09871","article-title":"Copy number variation and selection during reprogramming to pluripotency","volume":"471","author":"Hussein","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0340","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nature09805","article-title":"Somatic coding mutations in human induced pluripotent stem cells","volume":"471","author":"Gore","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0345","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1172\/JCI200112131","article-title":"Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes","volume":"108","author":"Kehat","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0350","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5966\/sctm.2013-0110","article-title":"Small molecule-mediated directed differentiation of human embryonic stem cells toward ventricular cardiomyocytes","volume":"3","author":"Karakikes","year":"2014","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0355","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.celrep.2012.09.015","article-title":"A small molecule that promotes cardiac differentiation of human pluripotent stem cells under defined, cytokine- and xeno-free conditions","volume":"2","author":"Minami","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0360","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1469-7580.2002.00031.x","article-title":"Cardiomyocyte differentiation of mouse and human embryonic stem cells","volume":"200","author":"Mummery","year":"2002","journal-title":"J. Anat."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0365","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nbt1327","article-title":"Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts","volume":"25","author":"Laflamme","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0370","doi-asserted-by":"crossref","first-page":"715","DOI":"10.5966\/sctm.2012-0161","article-title":"Trichostatin A enhances differentiation of human induced pluripotent stem cells to cardiogenic cells for cardiac tissue engineering","volume":"2","author":"Lim","year":"2013","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0375","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/nbt.2005","article-title":"SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells","volume":"29","author":"Dubois","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0380","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.scr.2014.04.016","article-title":"SIRPA, VCAM1 and CD34 identify discrete lineages during early human cardiovascular development","volume":"13","author":"Skelton","year":"2014","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0385","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1038\/ncomms3307","article-title":"Repopulation of decellularized mouse heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells","volume":"4","author":"Lu","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0390","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature12517","article-title":"Cerebral organoids model human brain development and microcephaly","volume":"501","author":"Lancaster","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0395","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nature09941","article-title":"Self-organizing optic-cup morphogenesis in three-dimensional culture","volume":"472","author":"Eiraku","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0400","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nbt.2958","article-title":"3D bioprinting of tissues and organs","volume":"32","author":"Murphy","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0405","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nature09747","article-title":"Modelling the long QT syndrome with induced pluripotent stem cells","volume":"471","author":"Itzhaki","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044660","article-title":"Cell model of catecholaminergic polymorphic ventricular tachycardia reveals early and delayed afterdepolarizations","volume":"7","author":"Kujala","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0415","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jacc.2012.02.066","article-title":"Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells","volume":"60","author":"Itzhaki","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0420","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature11799","article-title":"Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs","volume":"494","author":"Kim","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0425","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s12015-010-9210-x","article-title":"Generation of induced pluripotent stem cell lines from Friedreich ataxia patients","volume":"7","author":"Liu","year":"2011","journal-title":"Stem Cell Rev."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0430","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.stem.2010.09.014","article-title":"Friedreich's ataxia induced pluripotent stem cells model intergenerational GAATTC triplet repeat instability","volume":"7","author":"Ku","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0435","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1089\/scd.2013.0126","article-title":"Induced pluripotent stem cells from friedreich ataxia patients fail to upregulate frataxin during in vitro differentiation to peripheral sensory neurons","volume":"22","author":"Eigentler","year":"2013","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0440","first-page":"608","article-title":"Neurons and cardiomyocytes derived from induced pluripotent stem cells as a model for mitochondrial defects in Friedreich's ataxia","volume":"6","author":"Hick","year":"2013","journal-title":"Dis. Models Mech."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101718","article-title":"Functional characterization of Friedreich ataxia iPS-derived neuronal progenitors and their integration in the adult brain","volume":"9","author":"Bird","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2016.03.040_bb0450","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s00424-013-1414-x","article-title":"Modeling of Friedreich ataxia-related iron overloading cardiomyopathy using patient-specific-induced pluripotent stem cells","volume":"466","author":"Lee","year":"2014","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0455","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.ijcard.2015.11.101","article-title":"Efficient attenuation of Friedreich's ataxia (FRDA) cardiomyopathy by modulation of iron homeostasis-human induced pluripotent stem cell (hiPSC) as a drug screening platform for FRDA","volume":"203","author":"Lee","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0460","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/ana.24248","article-title":"Deferiprone in Friedreich ataxia: a 6-month randomized controlled trial","volume":"76","author":"Pandolfo","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0465","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00001573-200205000-00006","article-title":"Modifier genes for hypertrophic cardiomyopathy","volume":"17","author":"Marian","year":"2002","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.ijcard.2016.03.040_bb0470","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10571-008-9315-9","article-title":"A novel mitochondrial heteroplasmic C13806A point mutation associated with Iranian Friedreich's ataxia","volume":"29","author":"Heidari","year":"2009","journal-title":"Cell. Mol. Neurobiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316304521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316304521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:37:00Z","timestamp":1759091820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316304521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":94,"alternative-id":["S0167527316304521"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.03.040","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using human pluripotent stem cells to study Friedreich ataxia cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.03.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}